Search Results - "KELLY, Ciaran P"

Refine Results
  1. 1
  2. 2

    Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease by Leffler, Daniel, Schuppan, Detlef, Pallav, Kumar, Najarian, Robert, Goldsmith, Jeffery D, Hansen, Joshua, Kabbani, Toufic, Dennis, Melinda, Kelly, Ciarán P

    Published in Gut (01-07-2013)
    “…Coeliac disease is defined by gluten responsiveness, yet there are few data on gluten challenge (GC) in adults on a gluten-free diet. Lack of data regarding…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    Donor Screening for Fecal Microbiota Transplantation by Kassam, Zain, Dubois, Nancy, Ramakrishna, Bharat, Ling, Kelly, Qazi, Taha, Smith, Mark, Kelly, Colleen R, Fischer, Monika, Allegretti, Jessica R, Budree, Shrish, Panchal, Pratik, Kelly, Ciarán P, Osman, Majdi

    Published in The New England journal of medicine (21-11-2019)
    “…Restoration of a healthy stool microbiome has emerged as an approach to treat certain illnesses, including Clostridioides difficile colitis. In this report,…”
    Get full text
    Journal Article
  6. 6

    Body-Mass Index and Symptoms of Gastroesophageal Reflux in Women by Jacobson, Brian C, Somers, Samuel C, Fuchs, Charles S, Kelly, Ciarán P, Camargo, Carlos A

    Published in The New England journal of medicine (01-06-2006)
    “…Obesity is a known risk factor for gastroesophageal reflux disease. Among more than 10,000 women enrolled in the Nurses' Health Study, body-mass index was…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Determination of gluten consumption in celiac disease patients on a gluten-free diet by Syage, Jack A, Kelly, Ciarán P, Dickason, Matthew A, Ramirez, Angel Cebolla, Leon, Francisco, Dominguez, Remedios, Sealey-Voyksner, Jennifer A

    Published in The American journal of clinical nutrition (01-02-2018)
    “…Celiac disease (CD) patients adhering to a gluten-free diet (GFD) are exposed frequently to low levels of gluten that contribute to symptoms and persistent…”
    Get full text
    Journal Article
  9. 9

    Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence by Gerding, Dale N, Kelly, Ciaran P, Rahav, Galia, Lee, Christine, Dubberke, Erik R, Kumar, Princy N, Yacyshyn, Bruce, Kao, Dina, Eves, Karen, Ellison, Misoo C, Hanson, Mary E, Guris, Dalya, Dorr, Mary Beth

    Published in Clinical infectious diseases (16-08-2018)
    “…Abstract Background Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B indicated to prevent C. difficile infection (CDI)…”
    Get full text
    Journal Article
  10. 10

    Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial by Leffler, Daniel A, Kelly, Ciaran P, Green, Peter H.R, Fedorak, Richard N, DiMarino, Anthony, Perrow, Wendy, Rasmussen, Henrik, Wang, Chao, Bercik, Premysl, Bachir, Natalie M, Murray, Joseph A

    Published in Gastroenterology (New York, N.Y. 1943) (01-06-2015)
    “…Background & Aims Celiac disease (CeD) is a prevalent autoimmune condition. Recurrent signs and symptoms are common despite treatment with a gluten-free diet…”
    Get full text
    Journal Article
  11. 11

    Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4 by Junker, Yvonne, Zeissig, Sebastian, Kim, Seong-Jun, Barisani, Donatella, Wieser, Herbert, Leffler, Daniel A, Zevallos, Victor, Libermann, Towia A, Dillon, Simon, Freitag, Tobias L, Kelly, Ciaran P, Schuppan, Detlef

    Published in The Journal of experimental medicine (17-12-2012)
    “…Ingestion of wheat, barley, or rye triggers small intestinal inflammation in patients with celiac disease. Specifically, the storage proteins of these cereals…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI) by Leav, Brett A, Blair, Barbra, Leney, Mark, Knauber, Michael, Reilly, Courtney, Lowy, Israel, Gerding, Dale N, Kelly, Ciarán P, Katchar, Kia, Baxter, Roger, Ambrosino, Donna, Molrine, Deborah

    Published in Vaccine (22-01-2010)
    “…Abstract Background Previous studies have demonstrated a correlation between Clostridium difficile anti-toxin A serum antibodies and protection against…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity by Yu, Hua, Chen, Kevin, Sun, Ying, Carter, Mihaela, Garey, Kevin W, Savidge, Tor C, Devaraj, Sridevi, Tessier, Mary Elizabeth, von Rosenvinge, Erik C, Kelly, Ciaran P, Pasetti, Marcela F, Feng, Hanping

    Published in Clinical and vaccine immunology (01-08-2017)
    “…The host immune response affects pathogen virulence in infection (CDI). Thus, cytokine responses to CDI likely are associated with disease initiation and…”
    Get full text
    Journal Article
  17. 17

    Interruption of Recurrent Clostridium difficile-Associated Diarrhea Episodes by Serial Therapy with Vancomycin and Rifaximin by Johnson, Stuart, Schriever, Christopher, Galang, Minerva, Kelly, Ciarán P., Gerding, Dale N.

    Published in Clinical infectious diseases (15-03-2007)
    “…Eight women who each experienced 4–8 episodes of Clostridium difficile–associated diarrhea were given a 2-week course of rifaximin therapy when they were…”
    Get full text
    Journal Article
  18. 18

    Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection by Hu, Mary Y, Katchar, Kianoosh, Kyne, Lorraine, Maroo, Seema, Tummala, Sanjeev, Dreisbach, Valley, Xu, Hua, Leffler, Daniel A, Kelly, Ciarán P

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-2009)
    “…Background & Aims Prevention of recurrent Clostridium difficile infection (CDI) is a substantial therapeutic challenge. A previous prospective study of 63…”
    Get full text
    Journal Article
  19. 19

    Helicobacter pylori moves through mucus by reducing mucin viscoelasticity by Celli, Jonathan P, Turner, Bradley S, Afdhal, Nezam H, Keates, Sarah, Ghiran, Ionita, Kelly, Ciaran P, Ewoldt, Randy H, McKinley, Gareth H, So, Peter, Erramilli, Shyamsunder, Bansil, Rama

    “…The ulcer-causing gastric pathogen Helicobacter pylori is the only bacterium known to colonize the harsh acidic environment of the human stomach. H. pylori…”
    Get full text
    Journal Article
  20. 20

    Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias by Novack, Lena, Kogan, Slava, Gimpelevich, Larisa, Howell, Michael, Borer, Abraham, Kelly, Ciarán P, Leffler, Daniel A, Novack, Victor

    Published in PloS one (24-10-2014)
    “…An adverse effect of acid-suppression medications on the occurrence of Clostridium difficile infection (CDI) has been a common finding of many, but not all…”
    Get full text
    Journal Article